1:N
One person. Infinite leverage.

Justin Johnson
Lead, Data & AI Platforms
This isn't a portfolio. It's proof of what's possible when one person treats AI as a multiplier, not just a tool.
The Thesis
Over 18 months, I've built enterprise AI platforms serving hundreds of users, trained domain-specific foundation models, deployed autonomous trading systems, and created content reaching thousands—all while working as a solo practitioner leveraging agentic AI.
The "1:N" in the name captures this multiplier effect: one person producing the output that would traditionally require N people. Not by working longer hours, but by treating AI systems as capable collaborators.
The Multiplier Proof
Concrete examples of what AI leverage enables:
The Multiplier Effect
Drag the slider to see AI leverage in action
Enterprise Platform MVP
Without AI Leverage
9 months
With AI Leverage
2 weeks
Five Ways to See the Work
Bridge Builder
An enterprise leader who actually builds—not just manages. Strategy that ships code.
The Multiplier
Agentic AI leverage amplifying one human. What one person can do with the right tools.
The Lab
A personal R&D operation rivaling dedicated research teams. Foundation model training on DGX infrastructure.
The Stack
Full vertical integration from hardware (DGX) to production systems to published content.
Pioneer
First-mover on novel AI approaches—text diffusion, domain VLMs, autonomous agents.
About the Graph
The network visualization you see isn't just a pretty interface. It's a map of how ideas connect. Each node is a project. Each line is a relationship—what builds on what, what enables what, what's related to what.
Use the framing filters to see the same body of work through different lenses. Press ⌘K to search. Click any node to dive deeper.
The Meta-Story
This site itself is part of the proof. Built with Claude as a collaborator—from PRD to deployment in days, not weeks. The recursion is the point.
Run Data Run
View all →AI Ate the Keyboard. Now It Has to Eat the Queue.
Software stopped being the limiting factor. Process didn't. In biopharma and any patient-facing industry, the queue is the patient.
Jul 6, 2026Every AI Book Tells You What to Think. This One Is About What Your Hands Do.
There is a whole shelf of AI books for leaders now. I read enough of them to know why I wrote a different kind.
Jul 1, 2026The Gap, and the Book That Came Out of It
There's a line splitting the AI conversation that nobody's arguing about, because most people don't know it's there. I've spent months on the wrong-versus-right side of it. The book is out now.